Page last updated: 2024-08-26

bosentan anhydrous and Essential Polyarteritis

bosentan anhydrous has been researched along with Essential Polyarteritis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
García-Consuegra, J; González-Fernández, MA	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Essential Polyarteritis

Article	Year
Polyarteritis nodosa resistant to conventional treatment in a pediatric patient. The Annals of pharmacotherapy, 2007, Volume: 41, Issue:5 Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Arthralgia; Azathioprine; Bosentan; Child, Preschool; Cyclophosphamide; Female; Fever; Humans; Iloprost; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Polyarteritis Nodosa; Sulfonamides; Vasodilator Agents	2007

Article

Year

Polyarteritis nodosa resistant to conventional treatment in a pediatric patient.

The Annals of pharmacotherapy, 2007, Volume: 41, Issue:5

Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Arthralgia; Azathioprine; Bosentan; Child, Preschool; Cyclophosphamide; Female; Fever; Humans; Iloprost; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Polyarteritis Nodosa; Sulfonamides; Vasodilator Agents

2007